We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Signet Jewelers
SIG
$3.18B
| $3.75M | 0.07% |
27,000
-1,835
| -6% | -$227K |
|
152
Kinder Morgan
KMI
$70.2B
| $3.74M | 0.07% |
88,979
-1,931
| -2% | -$80K |
|
|
DD
153
DELISTED
Du Pont De Nemours E I
DD
| $3.63M | 0.07% |
53,433
-926
| -2% | -$66.1K |
|
154
Aemetis
AMTX
$135M
| $3.55M | 0.06% |
842,168
+104,708
| +14% | +$454K |
|
155
Wells Fargo
WFC
$257B
| $3.52M | 0.06% |
64,690
+265
| +0.4% | +$14.3K |
|
156
Chevron
CVX
$392B
| $3.34M | 0.06% |
31,812
-1,893
| -6% | -$202K |
|
157
3M
MMM
$92.2B
| $3.32M | 0.06% |
24,079
-642
| -3% | -$88.5K |
|
|
NORD
158
DELISTED
Nord Anglia Education, Inc.
NORD
| $3.32M | 0.06% |
146,003
-26,870
| -16% | -$555K |
|
159
AT&T
T
$174B
| $3.27M | 0.06% |
132,577
-5,318
| -4% | -$135K |
|
160
iShares MSCI Emerging Markets ETF
EEM
$31.4B
| $3.27M | 0.06% |
81,393
-1,708
| -2% | -$67.9K |
|
161
SPDR Gold Trust
GLD
$154B
| $3.17M | 0.06% |
27,873
-3,968
| -12% | -$464K |
|
|
NGLS
162
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
| $3.15M | 0.06% |
76,113
-852
| -1% | -$37.4K |
|
163
Toyota
TM
$227B
| $2.99M | 0.05% |
21,406
+11,706
| +121% | +$1.56M |
|
|
164
Accenture
ACN
$115B
| $2.99M | 0.05% |
31,914
-416,886
| -93% | -$37.2M |
|
165
Copa Holdings
CPA
$5.36B
| $2.99M | 0.05% |
29,574
-1,791
| -6% | -$194K |
|
|
TRIB
166
Trinity Biotech
TRIB
$7.93M
| $2.98M | 0.05% |
1,033
-117
| -10% | -$324K |
|
167
MPLX
MPLX
$60.3B
| $2.95M | 0.05% |
40,305
+3,505
| +10% | +$266K |
|
|
CEB
168
DELISTED
CEB Inc.
CEB
| $2.93M | 0.05% |
36,658
+7,386
| +25% | +$556K |
|
169
Equinor
EQNR
$98.6B
| $2.86M | 0.05% |
162,460
+67,702
| +71% | +$1.21M |
|
170
Honeywell
HON
$69.9B
| $2.79M | 0.05% |
29,782
+2
| +0% | +$183 |
|
171
Philip Morris
PM
$297B
| $2.78M | 0.05% |
36,860
+141
| +0.4% | +$11.4K |
|
172
Baxter International
BAX
$13.4B
| $2.77M | 0.05% |
74,446
-2,112
| -3% | -$80.1K |
|
|
FNGN
173
DELISTED
Financial Engines, Inc.
FNGN
| $2.76M | 0.05% |
66,013
+345
| +0.5% | +$13.6K |
|
174
Televisa
TV
$1.45B
| $2.74M | 0.05% |
83,055
-17,063
| -17% | -$574K |
|
|
PSXP
175
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $2.7M | 0.05% |
38,255
+3,665
| +11% | +$263K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.